SIETES :: 93213 citas

Resultados de la búsqueda por ASENAPINA

1.

Nadal M, Cols M. Hacia una mejor atención a los pacientes: medicamentos que hay que evitar y posibles alternativas.. Formación Médica Continuada en Atención Primaria 2016;23:231-44. [Ref.ID 100328]

2.

Leucht S, Cipriani A, Spineli L, Mavridis D, Örey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951-62. [Ref.ID 96106]

3.

Correli CU, De Hert M. Antipsychotics for acute schizophrenia: making choices. Lancet 2013;382:919-20. [Ref.ID 96104]

4.

George M, Amrutheshwar R, Rajkumar RP, Kattimani S, Dkhar SA. Newer antipsychotics and upcoming molecules for schizophrenia. Eur J Clin Pharmacol 2013;69:1497-509. [Ref.ID 95885]

5.

Anónimo. Pour mieux soigner: des médicaments à écarter. Prescrire 2013;33:138-42. [Ref.ID 94882]

6.

Kuehn BM. Off-label atypical antipsychotics. JAMA 2012;308:1198. [Ref.ID 93799]

7.

Anónimo. Asenapine for bipolar I disorder?. Drug Ther Bull 2012;50:69-72. [Ref.ID 93109]

8.

Miselli M. Asenapina. Informazioni sui Farmaci 2012;36:4-5. [Ref.ID 92777]

9.

Maher AR, Maglione M, Bagley S, Suttorp M, Hu J-H, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults. A systematic review and meta-analysis. JAMA 2011;306:1359-69. [Ref.ID 91219]

10.

Anónimo. Lurasidone (Latuda) for schizophrenia. Med Lett Drugs Ther 2011;53:13-4. [Ref.ID 90241]

11.

Frye MA. Bipolar disorder - A focus on depression. N Engl J Med 2011;364:51-9. [Ref.ID 90015]

12.

Spillane C. Fred Hassan sanguine over healthcare reforms. Scrip 2008;3419/20:10. [Ref.ID 84667]

13.

Moberly T. New data on Schering-Plough's asenapine presented. Scrip 2008;3365/66:19. [Ref.ID 83073]

14.

Anónimo. Pfizer claims growth in its R&D pipeline. Scrip 2004;2921:27. [Ref.ID 68887]